45% off EVERYTHING! Black Cyberday Starts November 27th!

CEM Store

CEM Store

Board Sponsor
Awards
1
  • Established
YK11 (also known by its chemical name (17α,20E)-17,20-[(1-methoxyethylidene)bis(oxy)]-3-oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester) is a promising new research compound found to be an agonist of the androgen receptor (AR) leading it to be classified as a SARM. YK11 research has also found it to possess a great ability to inhibit myostatin. These qualities have led to its growing use in muscle wasting/building research. YK11 activates the AR without causing unwanted side effects commonly associated in anabolic/androgenic research of the past.

YK11’s ability to inhibit myostatin plays a major role in its muscle and tissue building qualities. YK11 induces “myogenic differentiation of C2C12 cells and the expression of follistatin”. Follistatin plays a vital role in the tissue building and repair of many species and research notes; “increasing the amount of follistatin, resulted in greatly increased muscle mass”. This is clearly an important aspect to the anabolic effects seen in YK11 research and shows it’s a multifaceted compound with a wide array of research opportunities.

We are proud to offer you only the highest quality USA made YK11 for all of your research needs!

Liquid YK11 30mL 10mg/mL


Ref
1) YK11 is a partial agonist of the androgen receptor.Kanno Y1, Hikosaka R, Zhang SY, Inoue Y, Nakahama T, Kato K, Yamaguchi A, Tominaga N, Kohra S, Arizono K, Inouye Y. http://www.ncbi.nlm.nih.gov/pubmed/21372378
2) Selective androgen receptor modulator, YK11, regulates myogenic differentiation of C2C12 myoblasts by follistatin expression.Kanno Y1, Ota R, Someya K, Kusakabe T, Kato K, Inouye Y. http://www.ncbi.nlm.nih.gov/pubmed/23995658
 

Similar threads


Top